Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Current Assets:
Cash and cash equivalents	$ 130,633	$ 105,504
Short-term receivables - settlement and other	974,767	452,376
Prepaid expenses	273,552	400,416
Total Current Assets	1,378,952	958,296
Equipment and furnishings, less accumulated depreciation of $43,492 and $36,445, respectively	79,522	86,569
Patents, net of accumulated amortization of $10,480,657 and $10,145,098, respectively	1,234,787	1,570,347
Long-term receivable - reimbursable legal fees, net of reserve for uncollectibility of $455,500	455,500	455,500
Long-term receivable - settlement, net of discount and reserve for uncollectibility of $1,549,043	377,220	365,685
Total Assets	3,525,981	3,436,397
Current Liabilities:
Accounts payable - trade	3,500,467	3,270,505
Other accrued expenses	1,363,904	728,735
Total Current Liabilities	4,864,371	3,999,240
Convertible notes payable	6,412,000	4,456,000
Convertible notes payable - related parties	5,950,000	5,000,000
Total Liabilities	17,226,371	13,455,240
Commitments and contingencies
Stockholders' Deficiency:
Preferred stock; par value $0.001 per share; 25,000,000 shares authorized; Series B Convertible Preferred Stock; 240,000 shares designated; 100 shares issued and outstanding at June 30, 2018 and December 31, 2017; aggregate liquidation preference of $3,500 at June 30, 2018 and December 31, 2017
Common stock; par value $0.001 per share; 1,000,000,000 shares authorized; 383,111,028 and 370,961,451 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively	383,111	370,962
Additional paid-in capital	209,013,555	208,351,431
Accumulated deficit	(223,097,056)	(218,741,236)
Total Stockholder's Deficiency	(13,700,390)	(10,018,843)
Total Liabilities and Stockholders' Deficiency	$ 3,525,981	$ 3,436,397